Lung cancer palindromia due to the deficiency of vital energy and blood syndrome treated by TCM herbs - A case report

Sep 24, 2026

Lung cancer is a common primary malignant tumor with rising incidence and high mortality, and delayed detection often leads to missed optimal treatment windows. Surgery, radiotherapy, and chemotherapy remain standard, but occult progression, recurrence, and limited immunotherapy benefits restrict outcomes and survival. Traditional Chinese medicine (TCM) is presented as a targeted option with small adverse reactions, potentially alleviating radiotherapy/chemotherapy effects, improving tolerance, and extending patient lifespan.

LanguageEnglish

CategoryHealthcare

FormatPDF

Pages4

Reading Time10 min

AccessFree to download

Abstract

Rationale

Patient concerns

Diagnoses

Interventions

Outcomes

Lessons

Introduction

® Clinical Case Report Lung cancer palindromia due to the deficiency of vital energy and blood syndrome treated by TCM herbs A case report Xiaomeng Sun, PhDa , Dongyang Tan, MMa , Jiarui Miao, PhDa , Chang Wang, MMa , Yi Xu, MMa , Fei Yuan, BMa , Xu Fan, PhDa ,* | Abstract
Rationale: Lung cancer is a common primary malignant tumor of lung in clinic, which leads the world in both new cancers and new cancer deaths. At present, surgical treatment, radiotherapy and chemotherapy are commonly used in the treatment of lung cancer. However, due to the strong occultness of the diseases and the possibility of recurrence, the best treatment opportunity is often missed. Immunotherapy, which is the main method of lung cancer, but the treatment efficiency and survival are not satisfactory, most patients will have local recurrence or distant metastasis. Traditional Chinese medicine has a targeted effect on the treatment of lung cancer with small adverse reactions, and has a positive impact on alleviating the adverse reactions of radiotherapy and chemotherapy and prolonging the life span of patients. More and more attention should be paid to the research of lung cancer treatments.
Patient concerns: Patients with lung tumors, which had been surgically removed in the past. This time, the tumor occurred again, and the patient could not tolerate another surgical treatment. Other targeted treatments are not available due to financial and body constraints.
Diagnoses: The case was diagnosed as invasive adenocarcinoma of the upper lobe of the right lung.
Interventions: The patient received early surgical treatment, and then changed to traditional Chinese medicine (TCM) decoction treatment. The treatment principle of Chinese medicine is mainly to tonify healthy Qi and blood, enhancing the immunity of the body.
Outcomes: After nearly 2 years of TCM decoction treatment, the recurrent tumor has shrunk significantly. No discomfort such as fatigue, fever or weight loss. During this period, the patient did not receive western medical treatment such as surgery and chemotherapy, which did not affect normal life. It also proves that Chinese medicine is effective.
Lessons: This case report confirms that traditional Chinese medicine is safe and effective in the treatment of lung cancer, improving the ability of strengthening the health, driving away evil, and fighting cancer. TCM herbs can block the lesion of new blood vessels, anticancer metastasis, prevent recurrence after surgery, which is worth promoting. In clinical practice, the individual treatment of patients and the symptomatic treatment according to different syndromes should be attached great importance. Abbreviation: TCM = traditional Chinese medicine. | | --- | | Keywords: case report, lung cancer therapy, lung malignancy, traditional Chinese medicine decoction | 1. Introduction Lung cancer leads the world in both new cancers and new cancer deaths. The incidence and mortality rate of lung cancer in China is very high, which seriously affects the quality of life of patients. Affected by population aging, air pollution and smoking, the incidence and mortality of lung cancer are increasing year by year. China has become the country with the largest number of lung cancer patients. It is predicted that the number of lung cancer patients in China will reach 1 million by 2025.[1,2] This work was supported by the Basic Research Project of Education Department of Liaoning Province in 2022, China (LNKMZ20221307). Informed written consent was obtained from the patient for the purpose of publication of case details and images. The authors have no conflicts of interest to disclose. Data sharing not applicable to this article as no datasets were generated or analyzed during the current study. Ethics approval was waived as this was a case report. a Liaoning University of Traditional Chinese Medicine, Shenyang, China. * Correspondence: Xu Fan, Liaoning University of

FAQs

What diagnosis is reported in the case?

The case was diagnosed as invasive adenocarcinoma of the upper lobe of the right lung.

What treatment did the patient receive after recurrence?

The patient received early surgical treatment and then switched to traditional Chinese medicine (TCM) decoction therapy aimed at tonifying healthy Qi and blood and enhancing immunity.

What outcomes were observed during TCM decoction treatment?

After nearly two years, the recurrent tumor shrank significantly and the patient reported no discomfort such as fatigue, fever, or weight loss, without further Western treatment affecting normal life.

Sep 24, 2026

Uploaded by Valentina